• Info
  • Insider Trading

Thomas Malley - Insider Trading & Ownership

Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Summary
The estimated net worth of Thomas Malley is at least $17.5M dollars as of August 14, 2025. Thomas Malley is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $15.1M. Thomas Malley is the Director of Kiniksa Pharmaceuticals International, plc and owns shares of Kiniksa Pharmaceuticals International, plc (KNSA) stock worth about $2.39M.
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Thomas Malley files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Thomas Malley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONC, BEIGF BeiGene, Ltd. Director $15.1M Jun 15, 2023
KNSA Kiniksa Pharmaceuticals International, plc Director $2.39M -$5.86M -71% Aug 12, 2025
KURA Kura Oncology, Inc. Director Jun 5, 2025

Insider Transactions Reported by Thomas Malley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.